UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000859
Receipt number R000001032
Scientific Title Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers
Date of disclosure of the study information 2007/10/20
Last modified on 2010/02/17 20:45:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers

Acronym

Evaluation of the sedative effect of histamine H1 receptor antagonist by eye movement analyzing system

Scientific Title

Randomized, double blind, crossover clinical pharmacological study to evaluate the relationships between dose-, concentration in blood-, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis in healthy male volunteers

Scientific Title:Acronym

Evaluation of the sedative effect of histamine H1 receptor antagonist by eye movement analyzing system

Region

Japan


Condition

Condition

Healthy male volunteers

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is evaluate relationships between dose-, concentration in blood, and sedative effect after histamine H1 receptor antagonist d-chlorpheniramine intake using saccadic eye movement analysis

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Saccadic eye movement peak velocity

Key secondary outcomes

Visual analogue scale
Plasma concrntration of chlorpheniramine


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

d-Chlorpheniramine maleate 1 mg single oral dose

Interventions/Control_2

d-Chlorpheniramine maleate 2 mg single oral dose

Interventions/Control_3

d-Chlorpheniramine maleate 4 mg single oral dose

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1. Healthy male volunteer
2. Subjects are competent to consent, keep the rules of the study and are able to report self condition
3.Subjects who are judged eligible by the investigator in several series of medical check

Key exclusion criteria

1. Inappropriate clinical history for medication study (i.e. drug abuse, alcoholism, diseases of heart, liver, kidney, lung, and blood etc.) or who are ambulatory patients suffering theses diseases.
2. Subjects who are ingested medicine with sedatives or antihistaminic agents during this study.
3. Smoker
4. Any history for drug allergy.
5. Severe alcoholism.
6. Subjects who are inadequate for enrollment judged by the investigator.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshinori YAMAMOTO PhD.

Organization

Showa University School of Pharmaceutical Sciences

Division name

Department of Clinical Pharmacy

Zip code


Address

1-5-8 Hatanodai Shinagawa-ku Tokyo 142-8555

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Noriko KOHYAMA PhD.

Organization

Showa University School of Pharmaceutical Sciences

Division name

Department of Clinical Pharmacy

Zip code


Address


TEL


Homepage URL


Email

noriko-kyb@pharm.showa-u.ac.jp


Sponsor or person

Institute

Showa University School of Pharmaceutical Sciences
Department of Clinical Pharmacy

Institute

Department

Personal name



Funding Source

Organization

Grant-in Aid for Young Scientists (B)

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tsukuba Clinical Pharmacology Center Kan-nondai Clinic
Showa University School of Medicine Second Department of Pharmacology

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 10 Month 09 Day

Date of IRB


Anticipated trial start date

2007 Year 10 Month 01 Day

Last follow-up date

2007 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 10 Month 19 Day

Last modified on

2010 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001032